Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial
基于RBD-Fc的SARS-CoV-2重组疫苗Betuvax-CoV-2的安全性和免疫原性：首次人体随机、双盲、安慰剂对照I/II期临床试验的初步结果
期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines11020326
Kudriavtsev, Aleksandr V; Vakhrusheva, Anna V; Kryuchkov, Nickolay A; Frolova, Maria E; Blagodatskikh, Konstantin A; Ivanishin, Taras V; Djonovic, Milana; Romanovskaya-Romanko, Ekaterina A; Kovalenko, Anton N; Lioznov, Dmitry A; Zubkova, Tatiana G; Teplykh, Svetlana V; Oseshnyuk, Rodion A; Stukova, Marina A; Isaev, Artur A; Krasilnikov, Igor V
